Chapter 17 — The Record
“We did not need everyone to believe her. We needed a record that could survive someone deciding not to.”
— Nadia Rahal, What We Agreed To, 2053
Geneva, Switzerland — 2050
For fourteen days, Nadia had been turning the contents of Layla’s document case into a record other people could question.
There were two doors into the hearing room.
One opened toward the cameras.
The other led through a corridor where staff carried water, documents, and replacement microphones.
Nadia chose the second.
Amira followed her past a trolley of clean glasses.
“Are we avoiding them?”
“We’re arriving.”
“Through the service entrance.”
“Through a door.”
Ahead of them, Oksana held it open.
Amira almost smiled.
Inside, someone was testing a microphone.
The inquiry had no authority to award a prize.
It could not forgive Amira, repair her childhood, or require the public to accept its findings.
Its remit was narrower.
Examine the research records.
Assess the allegations concerning the foundation.
Establish what further investigation was warranted.
Recommend measures to protect people affected by the experimental program.
Tomas had explained the limits more than once.
Amira had found them frustrating.
This morning, she found them useful.
For once, someone had written down what a room could not promise.
Nadia checked the nameplates.
Then the document index.
Then the screen showing which exhibits would be visible during the public session.
“Page forty-three stays restricted,” she told the clerk.
“It’s marked.”
“I know. Please check the public copy.”
He did.
A moment later, he removed a page.
Nadia waited until the replacement was in place.
Amira watched from the table.
“What was it?”
“A name that isn’t yours to give.”
Layla sat two rows behind her.
Vera sat farther away, beside her own adviser.
Voss was present.
He had arrived early enough to choose a seat that faced the panel without facing Amira.
She looked at him once.
Then she opened the folder Nadia had prepared.
The first page was almost empty.
Three headings.
What I know.
What I did.
What I am asking.
Beneath them, in Nadia’s handwriting:
You can pause.
The chair began with procedure.
Some evidence would be heard publicly.
Material concerning other research subjects, private clinical information, and unverified identities would remain restricted.
The panel would publish reasons for its findings.
No conclusion had yet been reached.
Amira listened.
At the symposium, someone had put a photograph above her head and asked her to explain herself.
Here, the photograph was an exhibit.
Its source, date, completeness, and relevance could be questioned.
The difference was not dramatic.
It was everything.
“Dr. Nour, do you wish to make an opening statement?”
She adjusted the microphone.
“Yes.”
Her voice sounded ordinary.
She had expected it to sound different.
“I have spent the past weeks trying to separate several questions that became attached to my name at the same time.”
She looked at the panel.
“What was done to me before birth. What my parents understood. What I learned later. What I chose not to disclose. And whether the work produced by my colleagues and me performs as we have claimed.”
She turned the page.
“I am not asking you to answer one question in place of another.”
A panel member asked about 2035.
Amira described the accident, the neurological investigations, the records supplied afterward.
She did not repeat the entire medical history.
It was already before them.
“What did you understand at that point?”
“That an experimental biological architecture had been introduced during fetal development. That some findings were consistent with the surviving design records. That its influence on my life could not be reconstructed completely.”
“And what did you do?”
“Continued the clinical investigation. Spoke with my mother. Continued working.”
“Did you inform your institution?”
“Not of the full findings.”
“Why?”
Amira placed her hands on the table.
“Partly because they were medical findings whose implications remained uncertain.”
“And the other part?”
“I was afraid that uncertainty would become the only thing anyone saw.”
The panel member waited.
“I also wanted to keep what I had built.”
“Did your wish to preserve your career affect your decisions?”
“Yes.”
“Did you ever claim that your abilities had no unusual biological basis?”
“I allowed descriptions of me to stand that I would not have written myself.”
“That is not quite the question.”
“No.”
Amira took a breath.
“I do not recall making that specific claim. I do recall avoiding questions that might have led to a fuller answer.”
“Do you consider that acceptable now?”
“No.”
“Was it acceptable then?”
Amira looked down.
“It was understandable to me then.”
She raised her eyes.
“That is not the same thing.”
The technical session began before lunch.
Oksana moved to the witness table carrying a single folder.
The clerk offered to place her presentation on the screen.
“There are only four slides.”
Amira recognized the tone.
Someone had already tried to persuade her to include more.
The first slide showed the instrument’s documented operating limits.
The second summarized validation and independent testing.
The third listed corrections.
The fourth listed unresolved questions.
Oksana spent the longest time on the last two.
A panel member asked whether the device depended on an interpretation available only to Amira.
“No.”
“Did some design hypotheses originate with her?”
“Yes.”
“Could you have arrived at them without her?”
“I cannot tell you what a different history would have produced.”
“Then how do you separate her unusual abilities from the device?”
“We don’t need to separate them to test the device.”
Oksana indicated the report.
“We need procedures another team can follow, samples whose properties are independently established, defined criteria, and records of what happened.”
“And if the original insight came from the intervention?”
“The method would still have to work.”
She paused.
“And the intervention would still require ethical examination.”
Voss requested permission to clarify a point.
The chair allowed it.
“Reproducibility does not address every concern about scientific integrity.”
“No,” Oksana said.
“Nor does a useful result excuse a failure of disclosure.”
“No.”
“Then you accept that the foundation’s public account was incomplete?”
“Yes.”
Amira felt the room attend to the answer.
Oksana continued.
“I also accept that an incomplete account of a person’s medical history is not, by itself, evidence that water-testing results were fabricated.”
Voss looked toward the panel.
“My concern is broader than fabrication.”
“Then it should be stated specifically enough to investigate.”
The chair intervened.
“That is what this process is intended to establish.”
Voss sat back.
No one applauded.
Amira was grateful.
During the break, Nadia brought food to a small room off the corridor.
Oksana inspected the sandwiches.
“They’ve put the labels underneath.”
“Don’t start,” Nadia said.
“I’m not starting. I’m identifying.”
Amira sat beside the window.
For several minutes, they ate without discussing the hearing.
Then she said, “You didn’t defend me.”
Oksana lowered her sandwich.
“Yes, I did.”
“You agreed with him.”
“He was right about that part.”
Amira looked outside.
A maintenance worker was replacing a light fitting above the courtyard door.
Oksana continued.
“I said what I could support.”
“I know.”
After a moment, Amira turned back.
“Thank you.”
Layla gave evidence in the afternoon.
Before she began, she asked for water.
Her hand shook as she lifted the glass.
Amira had seen that hand steady a burner during a power cut. Sort medication. Hold a photograph over a flame.
She looked away until her mother set it down.
“Did you understand the intervention to be experimental?” the chair asked.
“Yes.”
“Did you understand the absence of prior human testing?”
“Yes.”
“Were you able to distinguish the proposed therapeutic purpose from the research purposes?”
“Not adequately at the time.”
“You were medically trained.”
“Yes.”
Layla did not try to make herself smaller than the record showed.
“I understood more than many parents would have. I was also frightened. Both things affected my decision.”
“Did anyone guarantee the intervention would save your child?”
“No.”
“Did anyone establish afterward that it had done so?”
“No.”
“Yet you described it that way.”
Layla looked toward Amira.
“Yes.”
“Why?”
“Because she lived.”
The room was quiet.
Layla pressed her fingers against the glass.
“Afterward, it became difficult to believe that anything we had done could have been unnecessary.”
The chair asked about later disclosure.
“When your daughter became old enough to understand, why did you not explain?”
“At first, I told myself she was too young.”
“And later?”
“That it would frighten her.”
“And when she was an adult?”
Layla took a long breath.
“That she was happy.”
Amira closed her eyes.
“I made her well-being a reason to keep the secret,” Layla continued. “When she struggled, I made that a reason too.”
“Did she ask questions?”
“Yes.”
“Did you answer truthfully?”
“Not always.”
“Did you destroy a photograph?”
“Yes.”
“Why?”
“Because she had found it.”
This time, Layla did not soften the sentence.
The restricted session concerned the continuation records.
Amira left the room for part of it.
She had chosen not to hear material identifying other subjects unless it was necessary to her own case.
In the corridor, she sat beside her mother.
Neither spoke.
After a while, Layla said, “I used to imagine the day you understood.”
Amira looked at her.
“In the version I imagined, you were relieved.”
“Were you?”
“No.”
Layla folded the tissue in her hand.
“I’m beginning to understand how much I needed that version.”
Amira did not reach for her.
She did not move away.
When the public session resumed, Vera confirmed her role in the continuation register.
She distinguished decisions she had signed from decisions she had inherited.
The panel required dates.
She supplied them.
Where documents were missing, the clerk marked them missing.
Where she could not remember, she said so.
“Did an absent objection become treated as agreement?” a panel member asked.
“In practice, yes.”
“Even when the subject had not been informed?”
“Yes.”
“Was that a defensible basis for continuing secondary research?”
“No.”
Amira watched Vera accept the word.
No.
Not qualified.
Not followed by an explanation of how much good the work might have done.
Just entered into the record.
The discussion returned to the proposed settlement.
“Did you understand that this agreement could limit Dr. Nour’s ability to discuss decisions made about her?”
Vera examined the marked provision.
“Yes.”
“What was its purpose?”
“To protect the inquiry, other participants, and material subject to competing confidentiality obligations.”
“Were those interests distinguished clearly enough?”
“No.”
“Could the agreement also have protected institutions from scrutiny?”
Vera looked up.
“Yes.”
Tomas wrote something beside Amira.
She did not need to read it.
Near the end, the chair invited Amira to address the measures she was requesting.
She turned to the last page.
Not a speech.
A list.
Access to her records, including the decisions attached to them.
Independent advice and continuing care for people affected by the program.
A process through which others could learn that records concerning them existed without being exposed publicly.
Preservation of evidence.
Review of research conducted beyond the purposes originally disclosed.
And a clear separation between protecting a subject’s privacy and concealing institutional responsibility.
She read slowly.
At the fourth point, her voice caught.
She stopped.
Nadia did not move to rescue the sentence.
Amira drank some water.
Then continued.
“Are you asking the inquiry to prohibit this category of research?” a panel member asked.
“I’m asking you not to confuse my survival with permission.”
“That does not answer the policy question.”
“No,” Amira said. “Because one person’s experience cannot settle every future use.”
She looked toward Layla.
“I will not tell another family that the decision is simple.”
Then toward Vera.
“But an emergency does not last for a person’s entire life. Whatever authority adults exercise for a child cannot become permanent ownership of that child’s future.”
The chair asked whether she had anything further.
Amira looked at the folder.
For weeks, people had asked what her abilities entitled her to.
A prize.
Trust.
Suspicion.
An exemption.
She thought of Salma identifying the wrong configuration.
Zahra asking when the results would arrive.
Nadia checking a page before it reached a public screen.
Oksana telling her that the method still had to work.
“Yes.”
She closed the folder.
“Examine my work.”
The chair waited.
“Examine my decisions. I have described omissions that belong to me. They should not be hidden behind what happened before I was born.”
Her voice steadied.
“But the decisions made before I could answer belong to other people. Please put their names beside them.”
The clerk asked her to confirm the final list of exhibits.
Public.
Restricted.
Incomplete.
Disputed.
Amira checked each designation with Nadia.
Then she signed the submission page.
The pen was ordinary.
So was the paper.
She had expected the act to feel larger.
Perhaps it would later.
Outside the room, Tomas warned them that findings would take time.
There might be further questions.
Additional witnesses.
Requests for clarification.
Amira nodded.
For once, she did not ask how long.
Nadia received the submission acknowledgment on her tablet.
She opened it, checked the attachments, and turned the screen toward Amira.
“It’s entered.”
Amira looked at the reference number.
“Can they change it?”
“They can add findings. Corrections. Responses.”
“But this?”
“This stays.”
Across the corridor, Layla waited beside the door.
Oksana stood with her coat over one arm.
No one looked triumphant.
Amira had not saved everything.
She did not yet know what the hearing would cost.
But the account no longer depended on a photograph someone could burn, a conversation someone could deny, or a page someone could quietly leave out.
She handed the tablet back.
Then she went to join them.
Historical Notes
UNESCO’s 2005 Universal Declaration on Bioethics and Human Rights sets out principles of informed consent, protection for people unable to consent, and respect for privacy. It distinguishes consent to research from other forms of authorization and states that personal information should, as far as possible, not be used or disclosed beyond its original or agreed purposes. These principles provide historical context for the fictional inquiry; the declaration is not itself a judgment about Meridian’s conduct or the law applicable to every event in the novel.
The 2023 European Code of Conduct for Research Integrity calls for fair investigations, consideration of relevant evidence, protection of confidentiality, and an opportunity for those accused to respond. It also recognizes that responsibility may extend beyond an individual researcher to institutions and organizations.
Archive Note
From the Independent Review Hearing Register, 2050:
The panel received the subject’s account, technical replication materials, and records concerning the developmental intervention and subsequent research use. Identifying information about other participants remained restricted. The proposed settlement was not executed. The panel reserved its findings and directed that the submitted evidence, including corrections and disputed interpretations, be preserved in the review record.
